within Pharmacolibrary.Drugs.P_AntiparasiticProductsInsecticidesAndRepellents.P02C_AntinematodalAgents.P02CX03_Moxidectin;

model Moxidectin
  extends Pharmacolibrary.Drugs.ATC.P.P02CX03;

  annotation (Documentation(
info       = "<html><body><table><tr><td>Drug:</td><td>P02CX03</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>2</td></tr></table><p>Moxidectin is a macrocyclic lactone anthelmintic used mainly for the treatment of onchocerciasis (river blindness) caused by Onchocerca volvulus, and is also effective against various gastrointestinal nematodes and ectoparasites in veterinary and human medicine. It is approved for human use in some countries for onchocerciasis and is under investigation for other indications.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters in healthy adult volunteers following a single oral dose.</p><h4>References</h4><ol><li><p>Tan, B, et al., &amp; Fleckenstein, L (2022). Pharmacokinetics of oral moxidectin in individuals with Onchocerca volvulus infection. <i>PLoS neglected tropical diseases</i> 16(3) e0010005–None. DOI:<a href=&quot;https://doi.org/10.1371/journal.pntd.0010005&quot;>10.1371/journal.pntd.0010005</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/35333880/&quot;>https://pubmed.ncbi.nlm.nih.gov/35333880</a></p></li><li><p>Cocquyt, CM, et al., &amp; Martín-Jiménez, T (2016). Pharmacokinetics of moxidectin in alpacas following administration of an oral or subcutaneous formulation. <i>Research in veterinary science</i> 105 160–164. DOI:<a href=&quot;https://doi.org/10.1016/j.rvsc.2015.12.011&quot;>10.1016/j.rvsc.2015.12.011</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/27033926/&quot;>https://pubmed.ncbi.nlm.nih.gov/27033926</a></p></li><li><p>West, G, et al., &amp; KuKanich, B (2017). PILOT STUDY: PHARMACOKINETICS OF ORAL AND TOPICAL MOXIDECTIN IN THE RETICULATED GIRAFFE (GIRAFFA CAMELOPARDALIS). <i>Journal of zoo and wildlife medicine : official publication of the American Association of Zoo Veterinarians</i> 48(2) 536–539. DOI:<a href=&quot;https://doi.org/10.1638/2016-0077R.1&quot;>10.1638/2016-0077R.1</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/28749301/&quot;>https://pubmed.ncbi.nlm.nih.gov/28749301</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
end Moxidectin;
